DRIO — DarioHealth Corp.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1533998 ·
Last close
$7.51
Market Cap
$54.92M
52W High
$12.00
52W Low
$6.20
ADV30
10,167
Next earnings
2026-08-14
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 5,584,000 3,200,000 -7,309,000 -8,249,000 103,281,000 14,977,000 40,901,000
Dec 2025 5,231,000 2,804,000 -8,562,000 -9,031,000 110,075,000 21,803,000 42,153,000
Sep 2025 5,007,000 3,015,000 -9,484,000 -10,466,000 117,727,000 31,907,000 42,793,000
Jun 2025 5,369,000 2,964,000 -9,200,000 -12,990,000 108,325,000 21,954,000 44,339,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-25,941,000
Investing CF
$-4,342,000
Financing CF
$24,313,000
CapEx
$-142,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-14.27
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-452,078,000
Inventory
$4,316,000
Receivables
$2,929,000
ST Investments
$4,214,000
EBIT TTM
$-35,769,000
Pretax Income TTM
$-41,609,000
Interest Exp TTM
$2,254,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$22,359,000
EBITDA
$-33,517,000
Free Cash Flow
$-11,204,875
Enterprise Value
$64,864,288
Total Cash
$26,017,000
Total Debt
$31,748,000
Shares Out
7,312,398
Trailing EPS
$-8.50
Book Value
$9.84
ROE
-59.6%
ROA
-20.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 22,359,000 -36,655,000 -41,714,000 110,075,000 42,153,000 -25,941,000
Dec 2024 27,040,000 -57,744,000 -42,747,000 118,884,000 46,865,000 -38,562,000
Dec 2023 20,352,000 -56,189,000 -59,427,000 96,389,000 38,245,000 -30,379,000
Dec 2022 27,656,000 -56,810,000 -62,193,000 119,191,000 39,192,000 -47,845,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.68

Peers — same industry

TickerNameMarket CapLastDaily %
POCI PRECISION OPTICS CORPORATION, INC. $54.40M $4.97
COCH Envoy Medical, Inc. $53.82M $0.70
SRTS Sensus Healthcare, Inc. $52.68M $3.20
MDNC Medinotec Inc. $58.78M $5.00
IDXG INTERPACE BIOSCIENCES, INC. $49.86M $1.80

News headlines (Yahoo Finance, 1h cache)

Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives
2026-05-26 12:00 · Yahoo
DarioHealth Corp (DRIO) Q1 2026 Earnings Call Highlights: Navigating Growth and Strategic ...
2026-05-13 23:01 · Yahoo
DarioHealth Q1 Earnings Call Highlights
2026-05-13 15:05 · Yahoo
DarioHealth Reports Q1 2026 Results: Full Earnings Call Transcript
2026-05-13 13:12 · Yahoo
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates
2026-05-13 11:25 · Yahoo
DarioHealth Reports First Quarter 2026 Financial and Operating Results
2026-05-13 10:30 · Yahoo
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
2026-05-12 00:05 · Yahoo
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 15:15 · Yahoo
DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
2026-05-04 12:30 · Yahoo
Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates
2026-05-04 12:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.